NHS Greater Glasgow and Clyde
86 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Laboratory Genetics, West of Scotland Genetic Services, Level 2B, Laboratory Medicine, Queen Elizabeth University Hospital, Govan Road
Glasgow G51 4TF , United Kingdom
Glasgow G51 4TF , United Kingdom
Accreditation
Active
UKAS
8290
ggc.scot.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8290
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
NHS Greater Glasgow and Clyde
10-16 Alexandra Parade
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
21 Shelley Road
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Paisley
NHS Greater Glasgow and Clyde
Glasgow
NHS Greater Glasgow and Clyde
Glasgow
Test Capabilities (86)
| Standard Reference | Description | Category |
|---|---|---|
| A, B, C, D, E | 11. Image capture for chromosome | A, B, C, D, E | 11. Image capture for chromosome | Histopathology / Cytology |
| A, B, C, D, E | 16. G banded bright field analysis | A, B, C, D, E | 16. G banded bright field analysis | Histopathology / Cytology |
| A, B, C, D, E | 17. Fluorescence in situ | A, B, C, D, E | 17. Fluorescence in situ | Histopathology / Cytology |
| A, B, C, D, E | 9. Slide staining for chromosome | A, B, C, D, E | 9. Slide staining for chromosome | Histopathology / Cytology |
| (ALL), including: | (MRD) | (ALL), including: | â–ª Minimal residual disease | Molecular Diagnostics / PCR |
| (LPN), including: | Leukaemia (CLL) | (LPN), including: | â–ª Chronic Lymphocytic | Molecular Diagnostics / PCR |
| (NGS, 5 gene panel) | NHS Greater Glasgow and Clyde | (NGS, 5 gene panel) | NHS Greater Glasgow and Clyde | Molecular Diagnostics / PCR |
| (acquired); | â–ª ALK1 | (acquired); | â–ª ALK1 | Molecular Diagnostics / PCR |
| (acquired); | â–ª BRAF | (acquired); | â–ª BRAF | Molecular Diagnostics / PCR |
| (acquired); | â–ª EGFR | (acquired); | â–ª EGFR | Molecular Diagnostics / PCR |
| (acquired); | â–ª ROS1 | (acquired); | â–ª ROS1 | Molecular Diagnostics / PCR |
| A Arthrogryposis (CE Subpanel) | EXAM-491 | A Arthrogryposis (CE Subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A Breast and Ovarian cancer | EXAM-147 | A Breast and Ovarian cancer | EXAM-147 | Molecular Diagnostics / PCR |
| A Breast, ovarian and colorectal | EXAM-147 | A Breast, ovarian and colorectal | EXAM-147 | Molecular Diagnostics / PCR |
| A DICER1 syndrome (CE) | EXAM-298 | A DICER1 syndrome (CE) | EXAM-298 | Molecular Diagnostics / PCR |
| A Dihydropyrimidine Dehydrogenase | EXAM – 495 | A Dihydropyrimidine Dehydrogenase | EXAM – 495 | Molecular Diagnostics / PCR |
| A Dilated Cardiomyopathy | EXAM-455 | A Dilated Cardiomyopathy | EXAM-455 | Molecular Diagnostics / PCR |
| A Familial Hemiplegic Migraine (FHM) | EXAM-296 | A Familial Hemiplegic Migraine (FHM) | EXAM-296 | Molecular Diagnostics / PCR |
| A Gorlin Syndrome (CE subpanel) | EXAM-491 | A Gorlin Syndrome (CE subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A Hereditary Ataxia (CE subpanel) | EXAM-491 | A Hereditary Ataxia (CE subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A Medium-chain acyl-coenzyme A | EXAM-477 | A Medium-chain acyl-coenzyme A | EXAM-477 | Molecular Diagnostics / PCR |
| A Neurodegeneration with Brain Iron | EXAM-491 | A Neurodegeneration with Brain Iron | EXAM-491 | Molecular Diagnostics / PCR |
| A Osteochondromas | EXAM-491 | A Osteochondromas | EXAM-491 | Molecular Diagnostics / PCR |
| A Osteopetrosis | EXAM-491 | A Osteopetrosis | EXAM-491 | Molecular Diagnostics / PCR |
| A Pancreatic Cancer (hereditary) 9 | EXAM-147 | A Pancreatic Cancer (hereditary) 9 | EXAM-147 | Molecular Diagnostics / PCR |
| A Respiratory Disease (CE subpanel) | EXAM-491 | A Respiratory Disease (CE subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A Rhabdoid tumour | EXAM-491 | A Rhabdoid tumour | EXAM-491 | Molecular Diagnostics / PCR |
| A Rhabdomyolysis (CE Subpanel) | EXAM-491 | A Rhabdomyolysis (CE Subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A SMA/dHMN (CE Subpanel) | EXAM-491 | A SMA/dHMN (CE Subpanel) | EXAM-491 | Molecular Diagnostics / PCR |
| A, B Chromosome investigation for | EXAM- 448, EXAM-453 | A, B Chromosome investigation for | EXAM- 448, EXAM-453 | Molecular Diagnostics / PCR |
| A, B Chromosome investigation for | [13,15,16,17] | A, B Chromosome investigation for | [13,15,16,17] | Molecular Diagnostics / PCR |
| A, B Epilepsy (NGS, 104 gene panel) | EXAM-126, EXAM-296 | A, B Epilepsy (NGS, 104 gene panel) | EXAM-126, EXAM-296 | Molecular Diagnostics / PCR |
| A, B Fragile X syndrome, including; | • FMR1-related disorders | A, B Fragile X syndrome, including; | • FMR1-related disorders | Molecular Diagnostics / PCR |
| A, B, C, D, E | 12. Sanger sequencing by capillary | A, B, C, D, E | 12. Sanger sequencing by capillary | Molecular Diagnostics / PCR |
| A, B, C, D, E | 13. Fragment analysis using PCR | A, B, C, D, E | 13. Fragment analysis using PCR | Molecular Diagnostics / PCR |
| A, B, C, D, E | 14. Next Generation sequencing | A, B, C, D, E | 14. Next Generation sequencing | Molecular Diagnostics / PCR |
| A, B, C, D, E | 15. Genomic profiling using 180kb | A, B, C, D, E | 15. Genomic profiling using 180kb | Molecular Diagnostics / PCR |
| A, B, C, D, E | 2. Automated and manual cDNA | A, B, C, D, E | 2. Automated and manual cDNA | Molecular Diagnostics / PCR |
| A, B, C, D, E | 425, EXAM-468 | A, B, C, D, E | 425, EXAM-468 | Molecular Diagnostics / PCR |
| A, B, C, D, E | 7. | A, B, C, D, E | 7. | Molecular Diagnostics / PCR |
| A, B, C, D, E | COBAS z480 realtime instruments | A, B, C, D, E | COBAS z480 realtime instruments | Molecular Diagnostics / PCR |
| A, B, C, D, E | Chemagic PRIME, Maxwell 48 | A, B, C, D, E | Chemagic PRIME, Maxwell 48 | Molecular Diagnostics / PCR |
| A, B, C, D, E | NextSeq500/550, Biomedical | A, B, C, D, E | NextSeq500/550, Biomedical | Molecular Diagnostics / PCR |
| A, B, C, D, E | Proflex thermocyclers, ABI7500and | A, B, C, D, E | Proflex thermocyclers, ABI7500and | Molecular Diagnostics / PCR |
| A, B, C, D, E | QuantStudio, GeneMarker, 7500 | A, B, C, D, E | QuantStudio, GeneMarker, 7500 | Molecular Diagnostics / PCR |
| A, B, E Cystic Fibrosis, including; | EXAM-449, EXAM-527 | A, B, E Cystic Fibrosis, including; | EXAM-449, EXAM-527 | Molecular Diagnostics / PCR |
| C Adult granulosa cell tumours | EXAM-528 | C Adult granulosa cell tumours | EXAM-528 | Molecular Diagnostics / PCR |
| C Colorectal Cancer (acquired) | EXAM-530 | C Colorectal Cancer (acquired) | EXAM-530 | Molecular Diagnostics / PCR |
| C Gastro-oesophageal cancer | EXAM-534 | C Gastro-oesophageal cancer | EXAM-534 | Molecular Diagnostics / PCR |
| C Ovarian cancer; | EXAM-414 | C Ovarian cancer; | EXAM-414 | Molecular Diagnostics / PCR |
| C Prostate cancer; | EXAM-414 | C Prostate cancer; | EXAM-414 | Molecular Diagnostics / PCR |
| C, D Endometrial tumour (2 gene panel) | • POLE | C, D Endometrial tumour (2 gene panel) | • POLE | Molecular Diagnostics / PCR |
| C, D Endometrial tumour (2 gene panel) | • TP53 | C, D Endometrial tumour (2 gene panel) | • TP53 | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • BRAF | Thyroid tumour (6 gene panel) | • BRAF | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • HRAS | Thyroid tumour (6 gene panel) | • HRAS | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • KRAS | Thyroid tumour (6 gene panel) | • KRAS | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • NRAS | Thyroid tumour (6 gene panel) | • NRAS | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • RET | Thyroid tumour (6 gene panel) | • RET | Molecular Diagnostics / PCR |
| Thyroid tumour (6 gene panel) | • TERT | Thyroid tumour (6 gene panel) | • TERT | Molecular Diagnostics / PCR |
| including; | (CML) | including; | (CML) | Molecular Diagnostics / PCR |
| including; | â–ª Essential Thrombocythaemia | including; | â–ª Essential Thrombocythaemia | Molecular Diagnostics / PCR |
| including; | â–ª Polycythaemia Vera | including; | â–ª Polycythaemia Vera | Molecular Diagnostics / PCR |
| A Chondrodysplasia Punctata (CE | EXAM-491 | A Chondrodysplasia Punctata (CE | EXAM-491 | Other |
| A Peripheral neuropathy (CE | EXAM-491 | A Peripheral neuropathy (CE | EXAM-491 | Other |
| A Short Stature, including: | EXAM-448, | A Short Stature, including: | EXAM-448, | Other |
| A, B, C, D, E | (VIP2000) and probe hybridisation | A, B, C, D, E | (VIP2000) and probe hybridisation | Other |
| A, B, C, D, E | 1. Process for the automated or | A, B, C, D, E | 1. Process for the automated or | Other |
| A, B, C, D, E | 2100 Bioanalyzer: EXAM-427 | A, B, C, D, E | 2100 Bioanalyzer: EXAM-427 | Other |
| A, B, C, D, E | 3. Automated cell separation and | A, B, C, D, E | 3. Automated cell separation and | Other |
| A, B, C, D, E | 427, EXAM-428 | A, B, C, D, E | 427, EXAM-428 | Other |
| A, B, C, D, E | 431 | A, B, C, D, E | 431 | Other |
| A, B, C, D, E | 5. PCR amplification of DNA and | A, B, C, D, E | 5. PCR amplification of DNA and | Other |
| A, B, C, D, E | 6. Robotic automation for pre and | A, B, C, D, E | 6. Robotic automation for pre and | Other |
| A, B, C, D, E | 8. Cell culture and harvesting of | A, B, C, D, E | 8. Cell culture and harvesting of | Other |
| A, B, C, D, E | EXAM-425 | A, B, C, D, E | EXAM-425 | Other |
| A, B, C, D, E | EXAM-426 | A, B, C, D, E | EXAM-426 | Other |
| A, B, C, D, E | EXAM-427 | A, B, C, D, E | EXAM-427 | Other |
| A, B, C, D, E | EXAM-497 | A, B, C, D, E | EXAM-497 | Other |
| A, B, C, D, E | EXAM-507, EXAM-524 | A, B, C, D, E | EXAM-507, EXAM-524 | Other |
| A, B, C, D, E | Ingenius3 and automated using | A, B, C, D, E | Ingenius3 and automated using | Other |
| A, B, C, D, E | MultiMACS and Sysmex XP-300: | A, B, C, D, E | MultiMACS and Sysmex XP-300: | Other |
| A, B, C, D, E | [1,4,5,6,7] | A, B, C, D, E | [1,4,5,6,7] | Other |
| A, B, C, D, E | [1,4,6] | A, B, C, D, E | [1,4,6] | Other |
| A, B, C, D, E | [3,8,9,11,12,13] | A, B, C, D, E | [3,8,9,11,12,13] | Other |
| Glioma) including; | EXAM-529 | Glioma) including; | EXAM-529 | Other |
| NHS Greater Glasgow and Clyde | NHS Greater Glasgow and Clyde | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.